Bayesian insights into fractional flow reserve-guided complete revascularization versus culprit-only percutaneous coronary intervention: The authors reply
Authors:
- 8 April 2026
- journal article
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 86, 97-98
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Fractional Flow Reserve–Guided Complete vs Culprit-Only Revascularization in Non–ST-Elevation Myocardial Infarction and Multivessel DiseaseJAMA, 2025
- Bayesian insights into fractional flow reserve-guided complete revascularization versus culprit-only percutaneous coronary intervention in patients with myocardial infarctionCardiovascular Revascularization Medicine, 2025
- Fractional flow reserve-guided complete revascularization versus culprit-only percutaneous coronary intervention in patients with myocardial infarction: A meta-analysis of randomized controlled trialsCardiovascular Revascularization Medicine, 2024
- FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial InfarctionNew England Journal of Medicine, 2024
- Complete or Culprit-Only PCI in Older Patients with Myocardial InfarctionNew England Journal of Medicine, 2023
- Fractional Flow Reserve–Guided Multivessel Angioplasty in Myocardial InfarctionNew England Journal of Medicine, 2017
- Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trialThe Lancet, 2015
- Random-effects meta-analysis: the number of studies mattersStatistical Methods in Medical Research, 2015
- Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trialNetherlands Heart Journal, 2012